ATC code L03AX (WHO) Synonyms Polyoxidonium, Synpol ChemSpider none | Bioavailability up to 89% CAS Number 892497-01-7 | |
 | ||
Biological half-life 25.4 hours (intravenous routes) | ||
Azoximer bromide is a macromolecular compound with high-molecular weight and high immunomodulating activity. It is used in Russia and CIS in treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative.
Azoximer bromide is registered in US Patent-5503830 from 1996, in the Russian Federation from 1996, under registration number 96/302/9, FS 42-3906-00.
Medical uses
In adults with secondary immunodeficient states as
- relapsing chronic bacterial infections
- relapsing chronic viral infections
- acute bacterial infections
- acute viral infections
- allergic diseases (pollinosis, bronchial asthma, atopic dermatitis)
- severe septic states
- postoperative complications - purulent infections
- when primary treatment develops cellular immunity decrease (cytostatic treatment, X-rays)